Skip to content

A study on the application of different concentrations of ropivacaine for proximal adductor canal combined with pes anserinus tendon block in anterior cruciate ligament reconstruction surgery

A study on the application of different concentrations of ropivacaine for proximal adductor canal combined with pes anserinus tendon block in anterior cruciate ligament reconstruction surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109297
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ruptured anterior cruciate ligament

Interventions

N1 group:proximal pudendal nerve block and gastrocnemius tendon block were performed, with 0.25% ropivacaine 15ml administered to each site
N2 group:proximal pudendal nerve block and gastrocnemius tendon block were performed, with 0.33% ropivacaine 15ml administered to each site
N3 group:proximal block of the adductor muscle tube and gastrocnemius tendon block were performed, with 0.5% ropivacaine 15ml applied to each site

Sponsors

Liuzhou People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years, gender unrestricted; 2. ASA classification I-II; 3. BMI value 18-30; 4. Patients undergoing arthroscopic anterior cruciate ligament reconstruction; 5. Able to complete the questionnaire independently or with the assistance of family members; 6. All patients and family members have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Infection at the puncture site; 2. Preoperative presence of neurological dysfunction or central nervous system diseases; 3. Severe psychological problems, those with a history of mental illness; 4. Severe heart or lung diseases or abnormal liver and kidney functions; 5. Abnormal coagulation function; 6. Chronic pain history, drug addicts; 7. Allergic to any component of analgesics; 8. Using other analgesic drugs within 24 hours; 9. Changing to other anesthesia methods.

Design outcomes

Primary

MeasureTime frame
Pain score;The time of the first postoperative ambulation;Quadriceps muscle strength;

Secondary

MeasureTime frame
Ramsay calm score;Was there any sudden pain 3 days after the operation?;The situation of additional painkillers administered in the ward 3 days after the surgery;Increase the dosage of tramadol and flurbiprofen axetil in the resuscitation room;The occurrence of postoperative adverse reactions (such as restlessness, dizziness, nausea, vomiting, etc.);

Countries

China

Contacts

Public ContactWang Xin

Liuzhou People’s Hospital

1351159197@qq.com+86 158 7829 2421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026